{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:54:38Z","timestamp":1792979678518,"version":"4.5.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2411800"],"award-info":[{"award-number":["2023YFC2411800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Clearance of circulating myoglobin is crucial to prevent further damage in patients with rhabdomyolysis (RM) and acute kidney injury (AKI). The objective of the present study was to evaluate the efficacy and safety of haemoadsorption (HA) combined with continuous renal replacement therapy (CRRT) in critically ill patients with RM and AKI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with RM and AKI who received CRRT\u00a0+\u00a0HA or CRRT with concomitant creatine kinase (CK) &amp;gt;10\u00a0000\u00a0IU\/l in our intensive care unit (ICU) between May 2021 and December 2023 were retrospectively included. The primary outcome was 90-day mortality; secondary outcomes were kidney function recovery and CK decline rate. Adverse events were also evaluated, including hypotension, circuit clotting, albumin leakage and blood loss. Propensity score matching and Cox retrospective analysis were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 111 RM patients with AKI were ultimately included. The ICU and in-hospital mortality were significantly lower in the CRRT\u00a0+\u00a0HA group compared with the CRRT group (ICU mortality: 18% versus 42%, P\u00a0=\u00a0.025; in-hospital mortality: 21% versus 42%, P\u00a0=\u00a0.048). However, the CRRT\u00a0+\u00a0HA group only showed a non-significant reduction in 90-day mortality compared with the CRRT group (47% versus 68%, P\u00a0=\u00a0.063). After treatment for 90\u00a0days, the number of patients with kidney function recovery was not significantly different between the CRRT\u00a0+\u00a0HA and CRRT groups (95% versus 84%, P\u00a0=\u00a0.639). Moreover, the incidence of hypotension and circuit clotting events did not increase during CRRT\u00a0+\u00a0HA treatment. In addition, the CRRT\u00a0+\u00a0HA group also appeared to have a higher rate of CK reduction and reduction of CK than the CRRT group at 24 and 48\u00a0hours after the initiation of CRRT. A multivariate Cox regression model demonstrated that CRRT\u00a0+\u00a0HA {hazard ratio [HR] 0.477 [95% confidence interval (CI) 0.234\u20130.972], P\u00a0=\u00a0.042}, mean arterial blood pressure [per 1\u00a0mmHg; HR 0.967 (95% CI 0.943\u20130.992), P\u00a0=\u00a0.009] and CRRT treatment duration [per 1\u00a0h; HR 0.995 (95% CI 0.992\u20130.998), P\u00a0=\u00a0.002] played a favourably important role in the survival prognosis of RM and AKI patients. In contrast, serum phosphate before RRT [per 1\u00a0mmol\/l; HR 1.531 (95% CI 1.113\u20132.106), P\u00a0=\u00a0.009] and McMahon score [per 1 score; HR 1.15 (95% CI 1.006\u20131.313), P\u00a0=\u00a0.04] were independent risk factors for 90-day mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CRRT combined with HA therapy reduced ICU and in-hospital mortality in patients with RM and AKI and also had a cleansing effect on creatine kinase without significant adverse events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae406","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:10:52Z","timestamp":1734484252000},"source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of haemoadsorption combined with continuous renal replacement therapy in patients with rhabdomyolysis and acute kidney injury: a retrospective study"],"prefix":"10.1093","volume":"18","author":[{"given":"Xiaochun","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Department of Nephrology, Guanghan Hospital of Traditional Chinese Medicine , Deyang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"2025022408451940500_bib1","doi-asserted-by":"publisher","first-page":"101015","DOI":"10.1016\/j.disamonth.2020.101015","article-title":"Rhabdomyolysis","volume":"66","author":"Cabral","year":"2020","journal-title":"Dis Mon"},{"key":"2025022408451940500_bib2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ajem.2018.12.061","article-title":"An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis","volume":"37","author":"Long","year":"2019","journal-title":"Am J Emerg Med"},{"key":"2025022408451940500_bib3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jemermed.2018.12.021","article-title":"Evaluation and management of acute compartment syndrome in the emergency department","volume":"56","author":"Long","year":"2019","journal-title":"J Emerg Med"},{"key":"2025022408451940500_bib4","first-page":"61","article-title":"Rhabdomyolysis: revisited","volume":"90","author":"Gupta","year":"2021","journal-title":"Ulster Med J"},{"key":"2025022408451940500_bib5","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1080\/0886022X.2022.2132170","article-title":"Earlier continuous renal replacement therapy is associated with reduced mortality in rhabdomyolysis patients","volume":"44","author":"Li","year":"2022","journal-title":"Ren Fail"},{"key":"2025022408451940500_bib6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1017\/cem.2020.37","article-title":"Just the facts: diagnosis and management of rhabdomyolysis","volume":"22","author":"Long","year":"2020","journal-title":"CJEM"},{"key":"2025022408451940500_bib7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00415-019-09185-4","article-title":"A systematic review on the definition of rhabdomyolysis","volume":"267","author":"Stahl","year":"2020","journal-title":"J Neurol"},{"key":"2025022408451940500_bib8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199003223221207","article-title":"Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis","volume":"322","author":"Better","year":"1990","journal-title":"N Engl J Med"},{"key":"2025022408451940500_bib9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ki.1996.48","article-title":"Rhabdomyolysis and myohemoglobinuric acute renal failure","volume":"49","author":"Zager","year":"1996","journal-title":"Kidney Int"},{"key":"2025022408451940500_bib10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-020-0645-1","article-title":"Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients","volume":"10","author":"Candela","year":"2020","journal-title":"Ann Intensive Care"},{"key":"2025022408451940500_bib11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N Engl J Med"},{"key":"2025022408451940500_bib12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000020651","article-title":"Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin","volume":"8","author":"Holt","year":"2000","journal-title":"Nephron Exp Nephrol"},{"key":"2025022408451940500_bib13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-016-1314-5","article-title":"Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice","volume":"20","author":"Chavez","year":"2016","journal-title":"Crit Care"},{"key":"2025022408451940500_bib14","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/ndt\/gfy162","article-title":"Histological manifestations of rhabdomyolysis in the kidney","volume":"33","author":"Bajema","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2025022408451940500_bib15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.freeradbiomed.2020.09.011","article-title":"Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury","volume":"160","author":"Grivei","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"2025022408451940500_bib16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.kint.2020.09.033","article-title":"Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis","volume":"99","author":"Boudhabhay","year":"2021","journal-title":"Kidney Int"},{"key":"2025022408451940500_bib17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-021-03531-7","article-title":"Extracorporeal myoglobin removal in severe rhabdomyolysis with high cut-off membranes-intermittent dialysis achieves much greater clearances than continuous methods","volume":"25","author":"Gubensek","year":"2021","journal-title":"Crit Care"},{"key":"2025022408451940500_bib18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1525-139X.2011.00892.x","article-title":"Does continuous renal replacement therapy have a role in the treatment of rhabdomyolysis complicated by acute kidney injury?","volume":"24","author":"Cruz","year":"2011","journal-title":"Semin Dial"},{"key":"2025022408451940500_bib19","doi-asserted-by":"publisher","first-page":"bcr2016218198","DOI":"10.1136\/bcr-2016-218198","article-title":"Hyponatraemia-induced rhabdomyolysis complicated by anuric acute kidney injury: a renal replacement conundrum","volume":"2016","author":"Secombe","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2025022408451940500_bib20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.injury.2010.08.031","article-title":"Myoglobin clearance by continuous venous-venous haemofiltration in rhabdomyolysis with acute kidney injury: a case series","volume":"43","author":"Zhang","year":"2012","journal-title":"Injury"},{"key":"2025022408451940500_bib21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF01690783","article-title":"Myoglobin clearance during acute continuous hemodiafiltration","volume":"17","author":"Bellomo","year":"1991","journal-title":"Intensive Care Med"},{"key":"2025022408451940500_bib22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13054-021-03468-x","article-title":"Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis","volume":"25","author":"Scharf","year":"2021","journal-title":"Crit Care"},{"key":"2025022408451940500_bib23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00134-022-06810-1","article-title":"Hemoperfusion in the intensive care unit","volume":"48","author":"Ricci","year":"2022","journal-title":"Intensive Care Med"},{"key":"2025022408451940500_bib24","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.3390\/ijms222312786","article-title":"Therapeutic modulation of the host defense by hemoadsorption with CytoSorb\u00ae\u2014basics, indications and perspectives\u2014a scoping review","volume":"22","author":"Kohler","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025022408451940500_bib25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-022-04009-w","article-title":"Hemoperfusion: technical aspects and state of the art","volume":"26","author":"Ronco","year":"2022","journal-title":"Crit Care"},{"key":"2025022408451940500_bib26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s13312-019-1661-9","article-title":"Cytosorb for management of acute kidney injury due to rhabdomyolysis in a child","volume":"56","author":"Padiyar","year":"2019","journal-title":"Indian Pediatr"},{"key":"2025022408451940500_bib27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1159\/000505899","article-title":"Successful reduction of creatine kinase and myoglobin levels in severe rhabdomyolysis using extracorporeal blood purification (CytoSorb\u00ae)","volume":"49","author":"Dilken","year":"2020","journal-title":"Blood Purif"},{"key":"2025022408451940500_bib28","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"2025022408451940500_bib29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2025022408451940500_bib30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2025022408451940500_bib31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"key":"2025022408451940500_bib32","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1159\/000368528","article-title":"Molecular mechanisms and novel therapeutic approaches to rhabdomyolysis-induced acute kidney injury","volume":"40","author":"Panizo","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"2025022408451940500_bib33","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.3390\/ijms23158215","article-title":"Rhabdomyolysis-induced AKI (RIAKI) including the role of COVID-19","volume":"23","author":"Mlynarska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025022408451940500_bib34","doi-asserted-by":"publisher","first-page":"e9742","DOI":"10.7759\/cureus.9742","article-title":"Role of bicarbonates and mannitol in rhabdomyolysis: a comprehensive review","volume":"12","author":"Somagutta","year":"2020","journal-title":"Cureus"},{"key":"2025022408451940500_bib35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12882-020-02104-0","article-title":"Risk factors for severe acute kidney injury among patients with rhabdomyolysis","volume":"21","author":"Yang","year":"2020","journal-title":"BMC Nephrol"},{"key":"2025022408451940500_bib36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s13054-020-03366-8","article-title":"Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial","volume":"24","author":"Weidhase","year":"2020","journal-title":"Crit Care"},{"key":"2025022408451940500_bib37","first-page":"54","article-title":"Characteristics of creatine kinase elevation in trauma patients and predictors of acute kidney injury","volume":"7","author":"Assanangkornchai","year":"2017","journal-title":"J Acute Med"},{"key":"2025022408451940500_bib38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/EJA.0000000000000490","article-title":"Rhabdomyolysis and acute kidney injury: creatine kinase as a prognostic marker and validation of the McMahon score in a 10-year cohort: a retrospective observational evaluation","volume":"33","author":"Simpson","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"2025022408451940500_bib39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/02656736.2022.2046183","article-title":"Serum myoglobin as predictor of acute kidney injury and 90-day mortality in patients with rhabdomyolysis after exertional heatstroke: an over 10-year intensive care survey","volume":"39","author":"Wu","year":"2022","journal-title":"Int J Hyperthermia"},{"key":"2025022408451940500_bib40","doi-asserted-by":"publisher","first-page":"2148024","DOI":"10.1155\/2021\/2148024","article-title":"Successful treatment of rhabdomyolysis-associated acute kidney injury with haemoadsorption and continuous renal replacement therapy","volume":"2021","author":"Hui","year":"2021","journal-title":"Case Rep Pediatr"},{"key":"2025022408451940500_bib41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13613-024-01334-x","article-title":"Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb\u00ae in patients with severe rhabdomyolysis: a prospective trial","volume":"14","author":"Graf","year":"2024","journal-title":"Ann Intensive Care"},{"key":"2025022408451940500_bib42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000534479","article-title":"Rapid and effective elimination of myoglobin with CytoSorb\u00ae hemoadsorber in patients with severe rhabdomyolysis","volume":"53","author":"Albrecht","year":"2024","journal-title":"Blood Purif"},{"key":"2025022408451940500_bib43","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","article-title":"Continuous renal replacement therapy: a worldwide practice survey. The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators","volume":"33","author":"Uchino","year":"2007","journal-title":"Intensive Care Med"},{"key":"2025022408451940500_bib44","doi-asserted-by":"publisher","first-page":"e000836","DOI":"10.1136\/tsaco-2021-000836","article-title":"Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus document","volume":"7","author":"Kodadek","year":"2022","journal-title":"Trauma Surg Acute Care Open"},{"key":"2025022408451940500_bib45","doi-asserted-by":"publisher","first-page":"1129156","DOI":"10.3389\/fped.2023.1129156","article-title":"Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy","volume":"11","author":"Zhou","year":"2023","journal-title":"Front Pediatr"},{"key":"2025022408451940500_bib46","doi-asserted-by":"publisher","first-page":"20543581221114697","DOI":"10.1177\/20543581221114697","article-title":"Association of serum phosphate derangement with mortality in patients on continuous renal replacement therapy","volume":"9","author":"Thongprayoon","year":"2022","journal-title":"Can J Kidney Health Dis"},{"key":"2025022408451940500_bib47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccc.2016.12.003","article-title":"Renal replacement therapy in acute kidney injury: controversies and consensus","volume":"33","author":"Heung","year":"2017","journal-title":"Crit Care Clin"},{"key":"2025022408451940500_bib48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/201187a0","article-title":"Evidence of fibrinogenuria in the nephrotic syndrome","volume":"201","author":"Yatzidis","year":"1964","journal-title":"Nature"},{"key":"2025022408451940500_bib49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000514149","article-title":"The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass","volume":"51","author":"He","year":"2022","journal-title":"Blood Purif"},{"key":"2025022408451940500_bib50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000489921","article-title":"Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion","volume":"46","author":"Pomar\u00e8 Montin","year":"2018","journal-title":"Blood Purif"},{"key":"2025022408451940500_bib51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5301\/ijao.5000492","article-title":"Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series","volume":"39","author":"Tr\u00e4ger","year":"2016","journal-title":"Int J Artif Organs"},{"key":"2025022408451940500_bib52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/biomedicines8120539","article-title":"Hemoadsorption with CytoSorb in septic shock reduces catecholamine requirements and in-hospital mortality: a single-center retrospective \u2018genetic\u2019 matched analysis","volume":"8","author":"Rugg","year":"2020","journal-title":"Biomedicines"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae406\/61218703\/sfae406.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/2\/sfae406\/61218703\/sfae406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/2\/sfae406\/61218703\/sfae406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:45:32Z","timestamp":1740386732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae406\/7926966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae406","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,17]]},"article-number":"sfae406"}}